Our Solutions

TESTIMONIALS

Find out what companies around the world are saying about working with Altasciences.

IDENIX logo

I am writing to recommend the services of Algorithme Pharma (now Altasciences). I have been using Algorithme Pharma (now Altasciences) services to conduct a Proof of Concept Phase I/IIa study in the therapeutic area of the Hepatic C Virus Infection starting in September 2013 and ending in January 2015.

They did an excellent job for this study: they were the 2nd better recruiter of HCV-infected subjects among 6 sites worldwide, always very transparent in their communication and with a focus on the quality.

As proofs of their performance:

  1. They completed the first part of the study in sequential dose escalation of Healthy Volunteers (48) and Genotype 1 HCV-infected subjects (15) in less than 3 months from regulatory submission to last subject dosed.
  2. They also successfully participated in the multiple dosing of several genotype HCV infected subjects and delivered 6 subjects within 2 months in a highly competitive environment.
  3. A sponsor audit of their systems at the CRO offices and the Phase I Unit was conducted on June 2014 (4 days) and no major finding was found. Only 4 minor audit observations and one comment were raised which proves the high quality standards of Algorithme Pharma (now Altasciences).

The team members from Algorithme Pharma (now Altasciences) were responsive, hard-working and client oriented. It was easy to work with them and they were always willing to take the time to discuss any concerns and respond to questions.

I feel confident in recommending Algorithme Pharma (now Altasciences) services.

If you need additional information please feel free to contact me.

Marie-Françoise TEMAM
Associate Director, Clinical Operations

Working as a flexible, attentive extension of your team, we offer comprehensive drug development services to move your molecule forward.

Sign up for exclusive content

Join our list of 10,000+ VIP members and have access to our exclusive content.

You can unsubscribe at any time. For more details, please review our privacy policy.

Stay connected